Robert Novak

WASHINGTON -- Near the top of the new Democratic congressional majority's agenda is passage of federal embryonic stem cell research legislation vetoed last year by President Bush, a measure that will answer a major question. There is no doubt the new bill will pass both houses of Congress. What remains in doubt are the votes to be cast by newly elected Democrats who campaigned as pro-life advocates, particularly Sen. Bob Casey Jr.

Outside the boundaries of his state of Pennsylvania, Casey is best known as the son of the Democrat most revered in the pro-life movement: the late Gov. Robert Casey. Denied the podium at the 1992 Democratic national convention because of anti-abortion views, the elder Casey planned a serious independent campaign for president before being stopped by poor health. But will the son, less ardent a pro-lifer than the father, vote against the stem cell research bill as he once promised during the campaign? Will seven self-described pro-life Democrats newly elected to the House do the same?

Casey's vote may determine whether Bush's second veto is overridden by the Senate. The House will probably sustain a veto, with or without help from the seven Democrats. But apart from the stem cell bill, at stake is whether pro-lifers have any place in today's Democratic Party. Certainly, that small fraction will be under intense pressure from party leaders.

Casey won a nationally spotlighted contest, defeating eminent Republican conservative Sen. Rick Santorum. He cut into Santorum's conservative base by winning 36 percent of the state's hard pro-life vote.

The only recorded statement by Casey on stem cell research came in an interview on the Catholic website on July 29, 2005: "I am and I have always been pro-life. I support the current [Bush administration] policy on embryonic stem cell research and would oppose the Castle bill to expand federal support of embryonic stem cell research."

That referred to the bill sponsored by Republican Rep. Mike Castle of Delaware that died in 2006 when the House sustained Bush's veto. But a new version is likely to be considered now in the Senate, where a supporter -- then Majority Leader Bill Frist -- conceded in a private session last year that the Castle bill was flawed and must be rewritten.

So, would Casey oppose any legislation that authorizes federally financed stem cell research on "left over" embryos from in-vitro fertilization clinics, as the Castle bill did? Casey the younger plays his cards close to his vest, and my efforts to get a commitment one way or another from the new senator or an aide were unavailing.

Robert Novak

Robert Novak (1931-2009) was a syndicated columnist and editor of the Evans-Novak Political Report.

©Creators Syndicate

Due to the overwhelming enthusiasm of our readers it has become necessary to transfer our commenting system to a more scalable system in order handle the content.

Check out Townhall's Polls on LockerDome on LockerDome